Debate Rages On Over ‘Black Box’ Warning on Antidepressants
The Carlat Child Psychiatry Report, Volume 5, Number 6, November 2014
https://www.thecarlatreport.com/newsletter-issue/ccprv5n6/
Issue Links: Learning Objectives | Editorial Information
Topics: Antidepressants | News of Note | Risk Management
The psychiatric community continues to debate the value of the US Food and Drug Administration’s (FDA) so-called ‘black box’ warning on certain antidepressants, and a pair of opposing viewpoints was recently featured in the New England Journal of Medicine.
You can't view details of this content, please login or buy subscription here